Preoperative treatment with PTX+B20 (paclitaxel chemotherapy plus anti-VEGF-A) effectively suppressed primary breast tumour growth compared to controls (Fig. 5a), but this did not translate into any appreciable improvement in OS (Fig. 5b). The gene discussed is VEGFA; the disease is breast neoplasm.